SCNX
Scienture Holdings, Inc.
Key Financials
Operating Income
$-42590842
↓ 189.7%
Gross Profit
$331482
↑ 5420.1%
Net Income
$-41512264
↓ 557.9%
EPS (Diluted)
$-2.70
↓ 208.9%
Total Assets
$84.2M
↓ 19.7%
Total Liabilities
$14.1M
↓ 45.5%
Revenue
$431609
↑ 215.9%
Shareholders' Equity
$70.1M
↓ 11.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SCNX |
| Company Name | Scienture Holdings, Inc. |
| CIK | 1382574 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (800) 261 0281 |